Physician profile
Amy L Keefer
NPI 1184884454
$1,088.75
in general payments reported to CMS, 2019-2025
13 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.56 · 2023: $269 · 2024: $410 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $284.04 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $191.97 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $174.78 | 2022-2025 | |
| Cequr Corporation | $120.73 | 2024-2025 | Cequr Simplicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.42 | 2024-2025 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $78.59 | 2022-2024 | Arexvy, Shingrix, Bexsero |
| Bayer Healthcare Pharmaceuticals INC. | $36.05 | 2024 | |
| Sonex Health, INC. | $33.80 | 2025 | Sx-One Microknife |
| Phathom Pharmaceuticals, INC. | $28.48 | 2024-2025 | Voquezna |
| Inspire Medical Systems, INC. | $15.39 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $15.13 | 2025 | Airsupra |
| Merck Sharp & Dohme LLC | $14.72 | 2024 | Gardasil, Gardasil 9, Vaxneuvance |
| Exact Sciences Corporation | $14.65 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Keefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.